Relational world of chronic pain patients in the course of an inpatient multimodal pain treatment focusing on psychosomatic interventions

Relational world of chronic pain patients in the course of an inpatient multimodal pain treatment focusing on psychosomatic interventions - BECSPIN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010256

Enrollment

Registered

2016-04-01

Start date

2016-04-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain F45.41 F45.40

Interventions

Group 1: Patients who meet the criteria for the multimodal pain treatment and who decided to do the therapy after visiting an information group. The criteria are written down by the German Institute

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of F45.41 or F45.40, having had a consultation in the outpatient unit and having taken part in the information group before deciding to take part in the treatment program.

Exclusion criteria

Exclusion criteria: not taking part in the treatment program

Design outcomes

Primary

Measure	Time frame
Dimensions of interoception: interoceptive accuracy, interoceptive sensibility and interoceptive awareness, as well as autonomous processes measured as (change in) vagal activity (via heart rate variability, HRV) (measured only in T1, T2, T3, T5). HRV and interoceptive accuracy are assessed via ECG with electrodes on the upper body (BIOPAC enhancer). This definitely is a non-invasive procedure. Interoceptive sensibility and awareness are assessed via body perception questionnaire (self-report). Timetable measures: T0-baseline, T1 start of the 5-week intervention, T2 2 weeks after start of the 5-week intervention, T3 end of 5-week intervention, T4 3 month after end of intervention, T5 12 month after end of intervention.	—

Measure

Time frame

Dimensions of interoception: interoceptive accuracy, interoceptive sensibility and interoceptive awareness, as well as autonomous processes measured as (change in) vagal activity (via heart rate variability, HRV) (measured only in T1, T2, T3, T5). HRV and interoceptive accuracy are assessed via ECG with electrodes on the upper body (BIOPAC enhancer). This definitely is a non-invasive procedure. Interoceptive sensibility and awareness are assessed via body perception questionnaire (self-report). Timetable measures: T0-baseline, T1 start of the 5-week intervention, T2 2 weeks after start of the 5-week intervention, T3 end of 5-week intervention, T4 3 month after end of intervention, T5 12 month after end of intervention.

—

Secondary

Measure	Time frame
All measures are assessed via self-reported questionnaires. Assessment baseline/T0: Pain history, utilisation (items adapted from the German Pain Questionnaire) and childhood trauma (Childhood Trauma Questionnaire). Assessment all measuring times T0-T5: Quality of life (SF-12), pain intensity and frequency (items adapted from the German Pain Questionnaire), clinical mental health (PHQ-9,-15-,-7). Assessment T1, T3, T4, T5: Empathie (Levels of emotional awareness scale & Empathy Quotient , Progredienzangst). During the 5-week intervention quality of therapeutic relationships within small groups will be assessed weekly as process variable with the Group Questionnaire (GQ-D).	—

Measure

Time frame

All measures are assessed via self-reported questionnaires. Assessment baseline/T0: Pain history, utilisation (items adapted from the German Pain Questionnaire) and childhood trauma (Childhood Trauma Questionnaire). Assessment all measuring times T0-T5: Quality of life (SF-12), pain intensity and frequency (items adapted from the German Pain Questionnaire), clinical mental health (PHQ-9,-15-,-7). Assessment T1, T3, T4, T5: Empathie (Levels of emotional awareness scale & Empathy Quotient , Progredienzangst). During the 5-week intervention quality of therapeutic relationships within small groups will be assessed weekly as process variable with the Group Questionnaire (GQ-D).

—

Countries

Germany

Contacts

Public ContactEva Rothermund

Universitätsklinikum für Psychosomatische Medizin und Psychotherapie, Ulm

eva.rothermund@uni-ulm.de+4973150061848

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026